Chart patterns in ilmn stock price forecast show ascending triangle formations, hinting at breakout potential if volume spikes occur alongside positive sector news. Are you a shareholder? It seems like the market has already priced in ILMN’s positive outlook, with shares trading around its fair value. However, there are also other important factors which we haven’t considered today, such as the track record of its management team. Have these factors changed since the last time you looked at the stock? Will you have enough confidence to invest in the company should the price drop below its fair value? Be the first to know the most important updates across all our datasets Investment banks updating ilmn stock price forecast advise cautious optimism. The biotech capital markets show resilience, and Illumina’s healthy balance sheet with over $1.5B in cash reserves provides flexibility for R&D scaling in 2024–
